Cargando…

Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma

PURPOSE: Plasma matrix metalloproteinase-1 (MMP-1) is a collagenase encoded by the MMP-1 gene. However, the prognostic value of plasma MMP-1 levels in oral cavity squamous cell carcinoma (OSCC) has yet to be elucidated. The study is the first to use a cohort of OSCC patients to assess the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Tsung-You, Kao, Huang-Kai, Huang, Yenlin, Chang, Ya-Ting, Young, Chi-Kuang, Hung, Shao-Yu, Chang, Yu-Sun, Yu, Jau-Song, Chang, Kai-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762675/ https://www.ncbi.nlm.nih.gov/pubmed/36545225 http://dx.doi.org/10.2147/CMAR.S389742

Ejemplares similares

Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma
por: Yeh, Chia-Chi, et al.
Publicado: (2023)

The role of postoperative radiotherapy in pN1 oral cavity cancer without extranodal extension
por: Tsai, Tsung-You, et al.
Publicado: (2021)

Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma
por: Huang, Yenlin, et al.
Publicado: (2020)

Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma
por: Adel, Mohamad, et al.
Publicado: (2015)

Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma
por: Chang, Kai-Ping, et al.
Publicado: (2015)

Endoplasmic reticulum aminopeptidase 2 involvement in metastasis of oral cavity squamous cell carcinoma discovered by proteome profiling of primary cancer cells
por: Kuo, I-Chun, et al.
Publicado: (2017)

Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells
por: Tsai, Chi-Neu, et al.
Publicado: (2019)

ASC contributes to metastasis of oral cavity squamous cell carcinoma
por: Wu, Chi-Sheng, et al.
Publicado: (2016)

Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma
por: Kao, Huang-Kai, et al.
Publicado: (2018)

Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma
por: Chen, Yu-Kuei, et al.
Publicado: (2016)

Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma
por: Yen, Wei-Chen, et al.
Publicado: (2022)

Increased Expression of Intranuclear Matrix Metalloproteinase 9 in Atrophic Renal Tubules Is Associated with Renal Fibrosis
por: Tsai, Jen-Pi, et al.
Publicado: (2012)

Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients
por: Ting, Wen-Chien, et al.
Publicado: (2013)

Prophylactic Administration of Fucoidan Represses Cancer Metastasis by Inhibiting Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinases (MMPs) in Lewis Tumor-Bearing Mice
por: Huang, Tse-Hung, et al.
Publicado: (2015)

Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017)

MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
por: Yen, Wei-Chen, et al.
Publicado: (2023)

Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV(1) at 5-Year Follow-up
por: Chung, Fu-Tsai, et al.
Publicado: (2019)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
por: Chiang, Ya-Tang, et al.
Publicado: (2023)

Expression of Matrix Metalloproteinases and Their Inhibitors in Squamous Cell Carcinoma of the Tonsil and Their Clinical Significance
por: Lee, Sei Young, et al.
Publicado: (2011)

Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma
por: Yu, Xiang-Yang, et al.
Publicado: (2022)

Matrix metalloproteinase profiling and their roles in disease
por: Chang, Mayland
Publicado: (2023)

Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma
por: Chung, I-Che, et al.
Publicado: (2014)

High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Hsin, Chung-Han, et al.
Publicado: (2014)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma
por: Huang, Chien-Chia, et al.
Publicado: (2019)

Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity
por: Yoshii, Noriko, et al.
Publicado: (2013)

Prognostic significance of the preoperative systemic immune‐inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy
por: Hung, Sheng‐Ping, et al.
Publicado: (2020)

Spontaneous metastases in immunocompetent mice harboring a primary tumor driven by oncogene latent membrane protein 1 from Epstein–Barr virus
por: Chang, Pu-Yuan, et al.
Publicado: (2016)

Outcomes of re-irradiation for oral cavity squamous cell carcinoma
por: Chen, Yen-Chao, et al.
Publicado: (2022)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
por: Huang, Hsien-Cheng, et al.
Publicado: (2022)

Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma
por: Chiang, Yin-Yin, et al.
Publicado: (2020)

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
por: Huang, Hui‐Chun, et al.
Publicado: (2021)

Impact of Flavonoids on Matrix Metalloproteinase Secretion and Invadopodia Formation in Highly Invasive A431-III Cancer Cells
por: Lin, Yo-Chuen, et al.
Publicado: (2013)

The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke
por: Chang, Jason J., et al.
Publicado: (2016)

Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline
por: Lo, Chun-Yu, et al.
Publicado: (2018)

Effects of Diosgenin on Myometrial Matrix Metalloproteinase-2 and -9 Activity and Expression in Ovariectomized Rats
por: Chang, Chi-Chen, et al.
Publicado: (2011)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing
por: Chou, Kuang-Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f4ngi91gngnlgodr74digsvr0i